We here see a similar situation in myeloma bone marrow, i.e., a high proportion of CD8+ T cells which lost CD28 expression and concomitantly gained CTLA-4 expression and upregulated 2B4. This evidence concerns the gene CTLA4 and plasma cell myeloma.